Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 2:08 pm Sale | 2022-12-31 | 13G | Surface Oncology, Inc. SURF | EcoR1 Capital LLC | 3,924,713 6.500% | -728,287 (-15.65%) | Filing History |
| 2023-02-13 1:55 pm Unchanged | 2022-12-31 | 13G | Arvinas, Inc. ARVN | EcoR1 Capital LLC | 3,123,300 5.900% | 0 (Unchanged) | Filing History |
| 2023-02-13 1:43 pm Purchase | 2022-12-31 | 13G | Xencor, Inc. XNCR | EcoR1 Capital LLC | 5,282,516 8.800% | 376,410 (+7.67%) | Filing History |
| 2023-02-13 08:25 am Purchase | 2022-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | EcoR1 Capital LLC | 157,934 9.900% | 29,402 (+22.88%) | Filing History |
| 2023-02-10 2:28 pm Purchase | 2022-12-31 | 13G | Ovid Therapeutics Inc. OVID | EcoR1 Capital LLC | 6,117,400 8.700% | 35,200 (+0.58%) | Filing History |
| 2023-02-10 1:59 pm Sale | 2022-12-31 | 13G | Akouos, Inc. AKUS | EcoR1 Capital LLC | 0 0.000% | -1,975,984 (Position Closed) | Filing History |
| 2023-02-10 1:56 pm Sale | 2022-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | EcoR1 Capital LLC | 3,418,068 7.600% | -50,876 (-1.47%) | Filing History |
| 2023-02-10 1:48 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | EcoR1 Capital LLC | 6,638,371 9.900% | 2,094,924 (+46.11%) | Filing History |
| 2023-02-10 1:48 pm Sale | 2022-12-31 | 13G | GRITSTONE BIO INC GRTSQ | EcoR1 Capital LLC | 0 0.000% | -6,319,232 (Position Closed) | Filing History |
| 2023-02-10 1:37 pm Purchase | 2022-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | EcoR1 Capital LLC | 6,184,861 7.400% | 808,727 (+15.04%) | Filing History |
| 2023-02-10 1:13 pm Sale | 2022-12-31 | 13G | Alector, Inc. ALEC | EcoR1 Capital LLC | 4,056,548 4.900% | -938,422 (-18.79%) | Filing History |
| 2023-02-09 5:55 pm Sale | 2022-12-31 | 13G | Solid Biosciences Inc. SLDB | EcoR1 Capital LLC | 0 0.000% | -613,513 (Position Closed) | Filing History |
| 2023-02-09 5:47 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital LLC | 0 0.000% | -1,975,611 (Position Closed) | Filing History |
| 2023-02-09 5:42 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital LLC | 0 0.000% | -5,523,358 (Position Closed) | Filing History |
| 2023-01-23 12:14 pm Purchase | 2023-01-10 | 13G | Revolution Medicines, Inc. RVMD | EcoR1 Capital LLC | 4,478,050 5.000% | 199,981 (+4.67%) | Filing History |
| 2023-01-20 5:32 pm Purchase | 2023-01-10 | 13G | Janux Therapeutics, Inc. JANX | EcoR1 Capital LLC | 3,255,270 7.800% | 3,255,270 (New Position) | Filing History |
| 2023-01-13 4:33 pm Sale | 2023-01-11 | 13G | Voyager Therapeutics, Inc. VYGR | EcoR1 Capital LLC | 3,851,507 9.980% | -425,000 (-9.94%) | Filing History |
| 2023-01-09 4:26 pm Purchase | 2023-01-06 | 13G | Graphite Bio, Inc. GRPH | EcoR1 Capital LLC | 1,219,778 14.700% | 403,764 (+49.48%) | Filing History |
| 2022-12-22 6:07 pm Purchase | 2022-12-12 | 13G | Adicet Bio, Inc. ACET | EcoR1 Capital LLC | 3,560,700 8.300% | 3,560,700 (New Position) | Filing History |
| 2022-11-23 12:28 pm Purchase | 2022-11-14 | 13G | Centessa Pharmaceuticals plc CNTA | EcoR1 Capital LLC | 5,232,279 5.500% | 5,232,279 (New Position) | Filing History |